Caina Technology Co

Caina Technology Co Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Caina Technology Co (301122.SZ) as of Nov 14, 2026 is 331.91 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 198.60 % — a change of 67.12% (higher).

Cash Conversion

331.91 %

YoY

67.12%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Caina Technology Co is 2025 331.91 % . Cash Conversion Rate (OCF/Net Income) of Caina Technology Co was 2024 198.60 % . It decreases by 67.12% higher compared to the previous year.

The Caina Technology Co Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2018
104.08 CNY
Jan 1, 2019
178.49 CNY
Jan 1, 2020
124.08 CNY
Jan 1, 2021
122.48 CNY
Jan 1, 2022
85.80 CNY
Jan 1, 2023
77.33 CNY
Jan 1, 2024
198.60 CNY
Jan 1, 2025
331.91 CNY
The Caina Technology Co Cash Conversion history
YEARCash ConversionYoY
331.91 %+67.12%
198.60 %+156.81%
77.33 %-9.87%
85.80 %-29.95%
122.48 %-1.29%
124.08 %-30.48%
178.49 %+71.49%
104.08 %+3,111.64%
3.24 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Caina Technology Co Stock analysis

What does Caina Technology Co do? Caina Technology Co., Ltd. manufactures medical consumables including puncture needles, syringes, laboratory consumables, and masks. The company's main products are reusable copper base injection needles, aluminum base injection needles, disposable aluminum-plastic inlaid injection needles, safety blood collection needles, sheathed syringes, disposable Sterile syringes, petri dishes, and reagent tubes. Caina Technology exports its products to the United States, the United Kingdom, and the European Union, serving international markets with its medical supplies. The company generates revenue through the sale of its medical consumables to global healthcare providers and distributors. Its product range targets hospitals, clinics, and laboratories requiring reliable medical equipment. Caina Technology's focus on exporting to developed markets ensures steady demand for its high-quality, compliant medical products. Caina Technology's business model relies on manufacturing and exporting medical consumables to international customers. The firm's product portfolio includes specialized items like safety blood collection needles and sterile syringes, which are essential for healthcare facilities. By targeting key regions such as the United States, United Kingdom, and European Union, the company secures consistent sales channels for its medical supplies. Caina Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Caina Technology Co stock

Cash Conversion Rate (OCF/Net Income) of Caina Technology Co is 331.91 % in 2025.

Cash Conversion Rate (OCF/Net Income) of Caina Technology Co changed from 198.60 % to 331.91 %, representing a 67.12% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Caina Technology Co since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Caina Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Caina Technology Co

All Key Metrics — Caina Technology Co